Question 1

Does Price T Rowe Associates own GILD stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Price T Rowe Associates holds 29,996,694 shares of GILD (Gilead Sciences), worth $3.8B.

Question 2

How many shares of GILD does Price T Rowe Associates own?

Accepted Answer

As of its Q2 2026 13F, Price T Rowe Associates holds 29,996,694 shares of GILD (Gilead Sciences).

Question 3

What is Price T Rowe Associates' GILD position worth?

Accepted Answer

As of its Q2 2026 13F, Price T Rowe Associates' GILD position is worth $3.8B.

Question 4

Is Price T Rowe Associates buying or selling GILD?

Accepted Answer

In Q2 2026, Price T Rowe Associates increased its GILD position by 3,748,586 shares (+14.3%).

Question 5

When did Price T Rowe Associates first buy GILD?

Accepted Answer

Price T Rowe Associates already held GILD in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	30M	+14.3%	$3.8B	0.4%	$125.63	43
2026-Q1	Decreased	26.2M	-5.2%	$3.7B	0.4%	$137.68	0
2025-Q4	Increased	27.7M	+4.5%	$3.4B	0.4%	$120.57	40
2025-Q3	Increased	26.5M	+12.4%	$2.9B	0.3%	$108.32	43
2025-Q2	Increased	23.6M	+60.4%	$2.6B	0.3%	$107.45	55
2025-Q1	Increased	14.7M	+314.6%	$1.6B	0.2%	$107.83	62
2024-Q4	Increased	3.5M	+5.9%	$327.6M	0.0%	$88.27	33
2024-Q3	Increased	3.3M	+17.7%	$280.7M	0.0%	$79.45	36

GILDShowing 8 of 28 quarters

GILD
Showing 8 of 28 quarters